NDC 0187-0453 – Zelapar

Selegiline Hydrochloride 1.25 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC0187-0453

Product details

Brand name
Zelapar
Generic name
Selegiline Hydrochloride
Labeler
Bausch Health US, LLC
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
NDA · NDA021479
Marketed since
June 14, 2006
Marketing end
July 31, 2028
Pharmacologic class
Monoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Zelapar →

Package NDC codes (1)

Package NDCDescriptionSince
0187-0453-026 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCHJun 14, 2006